GlassScriptPhysician profile
Mehrdad Rezaee
NPI 1629056692
$10,381.83
in general payments reported to CMS, 2019-2025
32 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $275 · 2021: $1,657 · 2022: $1,384 · 2023: $1,148 · 2024: $3,538 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,284 · Travel and Lodging: $1,447 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,284.10 |
| Travel and Lodging | $1,446.95 |
| Education | $200.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,690.72 | 2021-2025 | Corevalve Evolut R, Selectsecure, Micra |
| Philips North America LLC | $968.37 | 2019-2025 | (Br0) Coronary Atherectomy, Coronary Other, Specialty Tempus Ic Monitor |
| Pfizer INC. | $793.20 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $594.51 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $579.47 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Shockwave Medical, INC | $467.38 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $309.23 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $255.49 | 2019-2025 | |
| Abbott Laboratories | $160.95 | 2019-2025 | Assurity, Jot Dx, Mitraclip |
| Novo Nordisk INC | $157.39 | 2024-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $155.59 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $150.89 | 2022-2024 | Verquvo |
| Medtronic Vascular, INC. | $140.87 | 2019-2020 | |
| Amgen INC. | $126.35 | 2023-2025 | Repatha, Repatha |
| Akcea Therapeutics, INC. | $98.21 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $93.72 | 2024 | Arcalyst |
| Boston Scientific Corporation | $81.13 | 2020-2024 | Watchman Flx, Flextome Cutting Balloon |
| Esperion Therapeutics, INC. | $65.93 | 2024-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $61.08 | 2019-2020 | |
| Terumo Medical Corporation | $57.55 | 2022-2024 | Tr Band, Angio-Seal |
| Teleflex LLC | $48.31 | 2024 | Guideliner |
| Abiomed | $42.95 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.62 | 2019-2024 | Lifevest |
| Biotronik INC. | $36.52 | 2019-2023 | Selectra, Solia |
| Portola Pharmaceuticals, LLC | $34.93 | 2019 | |
| Cardiva Medical, INC. | $33.88 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $33.38 | 2023 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $26.51 | 2019 | |
| Getinge USA Sales, LLC | $25.17 | 2024 | Cardiosave Hybrid, Type B Plug |
| Kowa Pharmaceuticals America, INC. | $21.69 | 2019 | |
| Gilead Sciences, INC. | $20.19 | 2019 | |
| Asahi Intecc USA, INC. | $13.65 | 2023 | Asahi Ptca Guide Wire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehrdad Rezaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.